Abstract
Purpose
In Iran, cancers are the third leading cause of death, and gastrointestinal cancers are the primary cause of mortality among all the cancers. This study aimed to determine the trend of crude and age-standardized mortality rates (ASMR) for different types of gastrointestinal cancers over an 11-year period in Fars province (Iran).
Methods
In this study, all the mortality data for gastrointestinal cancers were derived from the Electronic Death Registration System (EDRS) between 2005 and 2015. Subsequently, we calculated the crude and age-standardized mortality rates (ASMR) and their trends for different types of gastrointestinal cancers based on age groups and gender over the study period.
Results
A total of 6547 deaths from gastrointestinal cancers were identified, with an average age of 66.0 ± 16.4 years. The crude and age-standardized mortality rates for gastrointestinal cancers were respectively 10.9 and 15.0 per 100,000 population in 2005 which significantly increased to 17.4 and 19.4 per 100,000 population in 2015 (P < 0.001). The ASMR for colon, pancreatic, and oral cancers showed an increasing trend; for small intestine cancers, a decreasing trend; and for esophageal, gastric, rectal, and hepatobiliary cancers displayed an almost constant trend.
Conclusions
Our study shows a higher ASMR and an increasing trend of gastrointestinal cancers in Fars province. Prevention and early diagnosis programs with screening techniques should be implemented to control the mortality rate of gastrointestinal cancers in the future.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.
Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate Int. 2018;6(2):41–5. https://doi.org/10.1016/j.prnil.2017.11.003.
Hassanipour S, Namvar G, Fathalipour M, Salehiniya H. The incidence of kidney cancer in Iran: a systematic review and meta-analysis. BioMedicine (France). 2018;8(2):22–7. https://doi.org/10.1051/bmdcn/2018080209.
Hassanipour S, Mohammadian-Hafshejani A, Ghoncheh M, Salehiniya H. The incidence and mortality of esophageal cancer and its relationship with development in the world. Biomed Res Ther J. 2017;4:1607.
Salehiniya H, Hassanipour S, Mansour-Ghanaei F, Mohseni S, Joukar F, Abdzadeh E, et al. The incidence of esophageal cancer in Iran: a systematic review and meta-analysis. Biomed Res Ther. 2018;5(7):2493–503.
Moradzadeh R, Golmohammadi P, Ghaitasi B, Nadrian H, Najafi A. Incidence of esophageal Cancer in Iran, a population-based study: 2001-2015. J Gastrointest Cancer. 2018. https://doi.org/10.1007/s12029-018-0114-3.
Reshadat S, Saeidi S, Zangeneh A, Ziapour A, Saeidi F, Choobtashani M. A comparative study of spatial distribution of gastrointestinal cancers in poverty and affluent strata (Kermanshah Metropolis, Iran). J Gastrointest Cancer. 2018. https://doi.org/10.1007/s12029-018-0163-7.
Salimzadeh H, Delavari F, Sauvaget C, Rezaee N, Delavari A, Kompani F, et al. Annual trends of gastrointestinal cancers mortality in Iran during 1990-2015; NASBOD study. Arch Iran Med. 2018;21(2):46–55.
Bray F, Soerjomataram I (2015) The changing global burden of cancer: transitions in human development and implications for cancer prevention and control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S (eds) Cancer: disease control priorities, third edition (volume 3). The International Bank for Reconstruction and Development / the World Bank (c) 2015 International Bank for Reconstruction and Development / the World Bank., Washington (DC). https://doi.org/10.1596/978-1-4648-0349-9_ch2.
Li D-J, Liang D, Song G-H, Li Y-W, Wen D-G, Jin J, et al. Upper gastrointestinal cancer burden in Hebei Province, China: a population-based study. World J Gastroenterol. 2017;23(14):2625–34. https://doi.org/10.3748/wjg.v23.i14.2625.
Van Malderen C, Van Oyen H, Speybroeck N. Contributing determinants of overall and wealth-related inequality in under-5 mortality in 13 African countries. J Epidemiol Community Health. 2013;67(8):667–76. https://doi.org/10.1136/jech-2012-202195.
O'Hare B, Makuta I, Chiwaula L, Bar-Zeev N. Income and child mortality in developing countries: a systematic review and meta-analysis. J R Soc Med. 2013;106(10):408–14. https://doi.org/10.1177/0141076813489680.
Khosravi A, Taylor R, Naghavi M, Lopez AD. Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ. 2007;85(8):607–14.
Abolverdi J, Ferdosifar G, Khalili D, Kamgar-Haghighi AA. Spatial and temporal changes of precipitation concentration in Fars province, southwestern Iran. Meteorog Atmos Phys. 2016;128(2):181–96.
Noroozian M. The elderly population in Iran: an ever growing concern in the health system. Iran J Psychiatry Behav Sci. 2012;6(2):1–6.
Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52–7.
Farkas K, Szucs M, Nyari TA. Trends in gastrointestinal cancer mortality rate in Hungary. Pathol Oncol Res. 2016;22(4):681–8. https://doi.org/10.1007/s12253-016-0052-y.
Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emergency (Tehran, Iran). 2015;3(1):16–21.
Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004;110(2):155–69. https://doi.org/10.1002/ijc.20097.
Malvezzi M, Carioli G, Bertuccio P, Boffetta P, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Annals of oncology: official journal of the European society for. Med Oncol. 2018;29(4):1016–22. https://doi.org/10.1093/annonc/mdy033.
Pourhoseingholi MA, Moghimi-Dehkordi B, Safaee A, Hajizadeh E, Solhpour A, Zali MR. Prognostic factors in gastric cancer using log-normal censored regression model. Indian J Med Res. 2009;129(3):262–7.
Pourhoseingholi MA, Baghestani A, Abadi A, Hajizadeh N. Iranian regional cancer incidence is misclassified in neighborhood's provinces. Gastroenterol Hepatol Bed Bench. 2016;9(2):75–7.
Sunkara V, Hebert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer. 2015;121(10):1563–9. https://doi.org/10.1002/cncr.29228.
Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013;24(10):2657–71. https://doi.org/10.1093/annonc/mdt301.
González-Santiago O, Yeverino-Gutiérrez ML, Del Rosario González-González M, Corral-Symes R, Morales-San-Claudio PC. Mortality assessment of patients with pancreatic cancer in Mexico, 2000-2014. Ecancermedicalscience. 2017;11:788–8. https://doi.org/10.3332/ecancer.2017.788.
Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VEPP, van Heijningen EB, Aragonés N, et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol. 2014;109(3):336–44. https://doi.org/10.1038/ajg.2013.420.
Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20 (11):2362–2368. doi:https://doi.org/10.1158/1055-9965.epi-11-0643.
Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006;12(43):7025–8. https://doi.org/10.3748/wjg.v12.i43.7025.
Joukar F, Mansour-Ghanaei F, Naghipour MR, Hassanipour S. Knowledge, distribution and risk factors of hepatitis B and C infection in high-risk groups in Guilan province, Iran. Hepat Mon. 2018;18(8). https://doi.org/10.5812/hepatmon.65870.
Moradi-Lakeh M, Esteghamati A. National Immunization Program in Iran: whys and why nots. Hum Vaccin Immunother. 2013;9(1):112–4. https://doi.org/10.4161/hv.22521.
Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of National Responsiveness to HBV vaccine after 22 years of Iranian expanded program on immunization (EPI): a systematic review and meta-analysis study. Hepat Mon. 2015;15(5):e23618–8. https://doi.org/10.5812/hepatmon.15(04)2015.23618.
Funding
This study was financially approved by Shiraz University of Medical Sciences, Shiraz, Iran (Grant number 96-01-109-14806).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was conducted in compliance with the provisions of the Helsinki Declaration. The protocol was approved by the ethics committee of Shiraz University of Medical Sciences (No. IR.SUMS.REC. 1396.S619).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nikbakht, HA., Sahraian, S., Ghaem, H. et al. Trends in Mortality Rates for Gastrointestinal Cancers in Fars Province, Iran (2005–2015). J Gastrointest Canc 51, 63–69 (2020). https://doi.org/10.1007/s12029-019-00204-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-019-00204-1